Clinical Commissioning Urgent Policy Statement: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease

Subcutaneous copper histidinate injections are recommended to be available through routine commissioning as a treatment option for presymptomatic neonates with classical Menkes disease within the criteria set out in this document.

Source:

NHS England